Cargando…
Assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes
External guide sequences (EGSs) are short antisense oligoribonucleotides that elicit RNase P-mediated cleavage of a target mRNA, which results in inhibition of gene expression. EGS technology is used to inhibit expression of a wide variety of genes, a strategy that may lead to development of novel t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108630/ https://www.ncbi.nlm.nih.gov/pubmed/27857983 http://dx.doi.org/10.1093/biomethods/bpw001 |
_version_ | 1782467394185199616 |
---|---|
author | Jackson, Alexis Jani, Saumya Davies-Sala, Carol Soler-Bistué, Alfonso J C Zorreguieta, Angeles Tolmasky, Marcelo E |
author_facet | Jackson, Alexis Jani, Saumya Davies-Sala, Carol Soler-Bistué, Alfonso J C Zorreguieta, Angeles Tolmasky, Marcelo E |
author_sort | Jackson, Alexis |
collection | PubMed |
description | External guide sequences (EGSs) are short antisense oligoribonucleotides that elicit RNase P-mediated cleavage of a target mRNA, which results in inhibition of gene expression. EGS technology is used to inhibit expression of a wide variety of genes, a strategy that may lead to development of novel treatments of numerous diseases, including multidrug-resistant bacterial and viral infections. Successful development of EGS technology depends on finding nucleotide analogs that resist degradation by nucleases present in biological fluids and the environment but still elicit RNase P-mediated degradation when forming a duplex with a target mRNA. Previous results suggested that locked nucleic acids (LNA)/DNA chimeric oligomers have these properties. LNA are now considered the first generation of compounds collectively known as bridged nucleic acids (BNAs) – modified ribonucleotides that contain a bridge at the 2ʹ,4ʹ-position of the ribose. LNA and the second-generation BNA, known as BNA(NC), differ in the chemical nature of the bridge. Chimeric oligomers containing LNA or BNA(NC) and deoxynucleotide monomers in different configurations are nuclease resistant and could be excellent EGS compounds. However, not all configurations may be equally active as EGSs. RNase P cleavage assays comparing LNA/DNA and BNA(NC)/DNA chimeric oligonucleotides that share identical nucleotide sequence but with different configurations were carried out using as target the amikacin resistance aac(6ʹ)-Ib mRNA. LNA/DNA gapmers with 5 and 3/4 LNA residues at the 5ʹ- and 3ʹ-ends, respectively, were the most efficient EGSs while all BNA(NC)/DNA gapmers showed very poor activity. When the most efficient LNA/DNA gapmer was covalently bound to a cell-penetrating peptide, the hybrid compound conserved the EGS activity as determined by RNase P cleavage assays and reduced the levels of resistance to amikacin when added to Acinetobacter baumannii cells in culture, an indication of cellular uptake and biological activity. |
format | Online Article Text |
id | pubmed-5108630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-51086302017-03-01 Assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes Jackson, Alexis Jani, Saumya Davies-Sala, Carol Soler-Bistué, Alfonso J C Zorreguieta, Angeles Tolmasky, Marcelo E Biol Methods Protoc Methods Manuscript External guide sequences (EGSs) are short antisense oligoribonucleotides that elicit RNase P-mediated cleavage of a target mRNA, which results in inhibition of gene expression. EGS technology is used to inhibit expression of a wide variety of genes, a strategy that may lead to development of novel treatments of numerous diseases, including multidrug-resistant bacterial and viral infections. Successful development of EGS technology depends on finding nucleotide analogs that resist degradation by nucleases present in biological fluids and the environment but still elicit RNase P-mediated degradation when forming a duplex with a target mRNA. Previous results suggested that locked nucleic acids (LNA)/DNA chimeric oligomers have these properties. LNA are now considered the first generation of compounds collectively known as bridged nucleic acids (BNAs) – modified ribonucleotides that contain a bridge at the 2ʹ,4ʹ-position of the ribose. LNA and the second-generation BNA, known as BNA(NC), differ in the chemical nature of the bridge. Chimeric oligomers containing LNA or BNA(NC) and deoxynucleotide monomers in different configurations are nuclease resistant and could be excellent EGS compounds. However, not all configurations may be equally active as EGSs. RNase P cleavage assays comparing LNA/DNA and BNA(NC)/DNA chimeric oligonucleotides that share identical nucleotide sequence but with different configurations were carried out using as target the amikacin resistance aac(6ʹ)-Ib mRNA. LNA/DNA gapmers with 5 and 3/4 LNA residues at the 5ʹ- and 3ʹ-ends, respectively, were the most efficient EGSs while all BNA(NC)/DNA gapmers showed very poor activity. When the most efficient LNA/DNA gapmer was covalently bound to a cell-penetrating peptide, the hybrid compound conserved the EGS activity as determined by RNase P cleavage assays and reduced the levels of resistance to amikacin when added to Acinetobacter baumannii cells in culture, an indication of cellular uptake and biological activity. Oxford University Press 2016-09-06 /pmc/articles/PMC5108630/ /pubmed/27857983 http://dx.doi.org/10.1093/biomethods/bpw001 Text en © The Author 2016. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Methods Manuscript Jackson, Alexis Jani, Saumya Davies-Sala, Carol Soler-Bistué, Alfonso J C Zorreguieta, Angeles Tolmasky, Marcelo E Assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes |
title | Assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes |
title_full | Assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes |
title_fullStr | Assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes |
title_full_unstemmed | Assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes |
title_short | Assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes |
title_sort | assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes |
topic | Methods Manuscript |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108630/ https://www.ncbi.nlm.nih.gov/pubmed/27857983 http://dx.doi.org/10.1093/biomethods/bpw001 |
work_keys_str_mv | AT jacksonalexis assessmentofconfigurationsandchemistriesofbridgednucleicacidscontainingoligomersasexternalguidesequencesamethodologyforinhibitionofexpressionofantibioticresistancegenes AT janisaumya assessmentofconfigurationsandchemistriesofbridgednucleicacidscontainingoligomersasexternalguidesequencesamethodologyforinhibitionofexpressionofantibioticresistancegenes AT daviessalacarol assessmentofconfigurationsandchemistriesofbridgednucleicacidscontainingoligomersasexternalguidesequencesamethodologyforinhibitionofexpressionofantibioticresistancegenes AT solerbistuealfonsojc assessmentofconfigurationsandchemistriesofbridgednucleicacidscontainingoligomersasexternalguidesequencesamethodologyforinhibitionofexpressionofantibioticresistancegenes AT zorreguietaangeles assessmentofconfigurationsandchemistriesofbridgednucleicacidscontainingoligomersasexternalguidesequencesamethodologyforinhibitionofexpressionofantibioticresistancegenes AT tolmaskymarceloe assessmentofconfigurationsandchemistriesofbridgednucleicacidscontainingoligomersasexternalguidesequencesamethodologyforinhibitionofexpressionofantibioticresistancegenes |